| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.03B | +812.0% |
| Gross profit | ¥0.00B | — |
| Operating income | ¥-0.02B | — |
| Net income | ¥-0.02B | — |
| Gross margin | 0.8% | Net margin -59.8% |
| Revenue Q/Q | -37.4% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.03B | 99.2% |
| R&D | ¥0.00B | 1.5% |
| SG&A | ¥0.02B | 46.8% |
| Tax & other | ¥0.00B | 0.4% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
德尔股份 ・ 景嘉微 ・ 香农芯创 ・ ST合纵 ・ 杭州高新 ・ 神思电子 ・ 光力科技 ・ 濮阳惠成 ・ 万孚生物 ・ 首华燃气 ・ 蓝海华腾 ・ 赛升药业
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies